Last Monday, the Pfizer - BioNTech vaccine received final approval from the US Food and Drug Administration (FDA). It is important to clarify that this approval does not mean that the vaccine was experimental until last Sunday. The experimental phase of this vaccine culminated with clinical trials in November 2020. During this experimental phase the company, in this case Pfizer, gathered the necessary evidence to determine that the vaccine is safe and over 90% effective in protecting against COVID-19 . Although its effectiveness has decreased somewhat with the appearance of the delta variant, the vaccine is still the best weapon to protect us from serious illness, hospitalization, or death from COVID-19.

Dr. Mónica Feliú-Mójer, Director of Communications and Science Outreach of the nonprofit organization Ciencia Puerto Rico, has been awarded the prestigious Emerson Collective Fellowship for her work using inclusive communication strategies to bring relevant and important information about COVID- 19 to Spanish-speaking communities. Dr. Feliú-Mójer is one of only 10 people throughout the United States and Puerto Rico recognized with this honor.

Committed to his country and his alma mater, the engineer José M. Rodríguez, a graduate of the Mayagüez University Campus (RUM), of the University of Puerto Rico (UPR), is a flagship plant in his work as Director of Engineering for the Americas in Abbott Laboratories company, where it is a leader of vital initiatives today to combat COVID-19.

To read the full news story, please access the Spanish version of this website.